Category: Entrepreneurship

“The Future Is Rich in Opportunity”

(p. A13) Ken Langone, 82, investor, philanthropist and founder of Home Depot, has written an autobiography that actually conveys the excitement of business–of starting an enterprise that creates a job that creates a family, of the joy of the deal and the place of imagination in the making of a career. Its hokey and ebullient name is “I Love Capitalism” which I think makes his stand clear.
. . .
Can capitalism win the future? “Yes, but we have to be more emphatic and forthright about what it is and its benefits. A rising tide does lift boats.”
Home Depot has changed lives. “We have 400,000 people who work there, and we’ve never once paid anybody minimum wage.” Three thousand employees “came to work for us fresh out of high school, didn’t go to college, pushing carts in the parking lot. All 3,000 are multimillionaires. Salary, stock, a stock savings plan.”
Mr. Langone came up in the middle of the 20th century–the golden age of American capitalism. Does his example still pertain to the 21st? Yes, he says emphatically: “The future is rich in opportunity.” To see it, look for it. For instance: “Look, people are living longer. They’re living more vibrant lives, more productive. This is an opportunity to accommodate the needs of older people. Better products, cheaper prices–help them get what they need!”
Mr. Langone grew up in blue-collar Long Island, N.Y. Neither parent finished high school. His father was a plumber who was poor at business; his mother worked in the school cafeteria. They lived paycheck to paycheck. He was a lousy student but he had one big thing going for him: “I loved making money.” He got his first job at 11 and often worked two at a time–paperboy, butcher-shop boy, caddie, lawn work, Bohack grocery clerk. He didn’t mind: “I wanted to be rich.”

For the full commentary, see:
Peggy Noonan. “DECLARATIONS; Wisdom of a Non-Idiot Billionaire.” The Wall Street Journal (Saturday, May 12, 2018): A13.
(Note: ellipsis added.)
(Note: the online version of the commentary has the date May 10, 2018.)

The book mentioned in the commentary, is:
Langone, Ken. I Love Capitalism!: An American Story. New York: Portfolio, 2018.

Blockchain May Enable “Consent-Based Ad Models”

(p. A13) Internet advertising started simply, but over time organically evolved a mess of middle players and congealed into a surveillance economy. Today, between end users, publishers and advertisers stand a throng of agencies, trading desks, demand side platforms, network exchanges and yield optimizers. Intermediaries track users in an attempt to improve revenue.
It’s an inevitable consequence of such a system that users end up treated as a resource to be exploited. When you visit the celebrity website TMZ, for instance, you face as many as 124 trackers, according to a Crownpeak test. Your data is stored and profiled to retarget promotions that shadow you around the Internet. You become the product. Some claim your data is not “sold,” but access is certainly rented out.
. . .
For a solution, look to blockchain technology. More than a word peppering earnings calls, it can deliver the change brands, publishers and users need. Put simply, it’s an immutable database that records transactions and produces trustworthy data.
In advertising, blockchain’s reliable data can radically shrink the ad-tech blob and provide the foundation for consent-based ad models. Improved blockchain reporting and transparency would obviate much of the need for companies focused on measurement, verification and even some data suppliers. Companies like Brave are using blockchain to build software that allows for more-direct relationships between advertisers and publishers, as it was before the blob. (Earlier this month Brave announced a partnership with Dow Jones Media Group, a division of this newspaper’s parent company.) Anonymous data on the blockchain or on a device can even replace the need for the mining of individual user data. Users should be compensated for their attention and seen as customers again.
The internet need not be characterized by predation and parasitism. It can once again be a place of infinite possibility. Innovation got us into this situation; it can get us out.

For the full commentary, see:
Brendan Eichand and Brian Brown. “The Internet’s ‘Original Sin’ Endangers More Than Privacy.” The Wall Street Journal (Saturday, April 28, 2018): A13.
(Note: ellipsis added.)
(Note: the online version of the commentary has the date April 27, 2018.)

Jeff Bezos Is “Exploring Strange New Worlds”

(p. A15) Jeff Bezos is the world’s richest person. Amazon is on a tear–sales grew 43% last quarter–and may soon pass Apple as the world’s most valuable company. Amazon has ruptured retail, floated in the cloud, and even made superhero TV shows like “The Tick.” But what makes Mr. Bezos tick?
. . .
. . . , Mr. Bezos is now channeling pioneers, be they Columbus or James T. Kirk, exploring strange new worlds. His strategy is that he doesn’t let business models get in his way while exploring on the edge.
. . .
I’m convinced the real secret to Mr. Bezos’s success is that he hates PowerPoint slides. He insists instead on six-page narratives at meetings. Stories codify exploration. Here’s one: Put Alexa in every doctor’s office to listen and correctly fill in medical records automatically from the transcripts, freeing doctors to actually care for patients! Business model to come (but pretty obvious).

For the full commentary, see:
Andy Kessler. ” INSIDE VIEW; Columbus Discovers the Amazon.” The Wall Street Journal (Monday, May 7, 2018): A15.
(Note: ellipses added.)
(Note: the online version of the commentary has the date May 6, 2018.)

China’s “Double Whammy for Prospective Entrepreneurs”

(p. B12) China’s past attempts to stoke indigenous innovation have a checkered history. A flood of cheap capital and high, state-set solar power rates in the mid-2000s secured China’s place as the world’s number one solar cell manufacturer. But it also led to enormous overcapacity, which sank prices and pushed debt burdens higher, making investment in real R&D more difficult. For investors, China’s solar champions have been a losing proposition–American depositary receipts of top firms such as JinkoSolar are worth less than half of their peak in 2010. Robotics, a key element of Beijing’s “Made in China 2025” plan to dominate high-tech manufacturing, is exhibiting similar tendencies.
The state-centric nature of China’s financial system–and its weak intellectual property protection–represents a double whammy for prospective entrepreneurs. Small private-sector firms often only have access to capital through expensive shadow banking channels, and face the risk that some better connected, state-backed firm will make off with their designs–with very little recourse.

For the full story, see:
Nour Malas and Paul Overberg. “‘Chinese Innovation Won’t Come Easily Without U.S. Tech.” The Wall Street Journal (Tuesday, March 23, 2018): B12.
(Note: the online version of the story has the date March 22, 2018, and has the title “Can China’s Red Capital Really Innovate?”)

The Diversity That Matters Most Is Diversity of Thought

(p. A15) If you want anyone to pay attention to you in meetings, don’t ever preface your opposition to a proposal by saying: “Just to play devil’s advocate . . .” If you disagree with something, just say it and hold your ground until you’re convinced otherwise. There are many such useful ideas in Charlan Nemeth’s “In Defense of Troublemakers,” her study of dissent in life and the workplace. But if this one alone takes hold, it could transform millions of meetings, doing away with all those mushy, consensus-driven hours wasted by people too scared of disagreement or power to speak truth to gibberish. Not only would better decisions get made, but the process of making them would vastly improve.
. . .
In the latter part of her book, Ms. Nemeth explores in more detail how dissent improves the way in which groups think. She is ruthless toward conventional “brainstorming,” which tends toward the uncritical accumulation of bad ideas rather than the argumentative heat that forges better ideas. It’s only through criticism that concepts receive proper scrutiny. “Repeatedly we find that dissent has value, even when it is wrong, even when we don’t like the dissenter, and even when we are not convinced of his position,” she writes. “Dissent . . . enables us to think more independently” and “also stimulates thought that is open, divergent, flexible, and original.”
. . .
Ms. Nemeth’s punchy book also has an invaluable section on diversity in groups. All too often, she writes, in pursuit of diversity we focus on everything but the way people think. We look at a group’s gender, color or experience, and once the palette looks right declare it diverse. But you can have all of that and still have a group that thinks the same and reinforces a wrong-headed consensus.
By contrast, you can have a group that is demographically homogeneous yet violently heterogeneous in the way it thinks. The kind of diversity that leads to well-informed decisions is not necessarily the kind of diversity that gives the appearance of social justice. That will be a hard message for many organizations to swallow. But as with many of the arguments that Ms. Nemeth makes in her book, it is one that she gamely delivers and that all managers interested in the quality and integrity of their decision-making would do well to heed.

For the full review, see:
Philip Delves Broughton. “BOOKSHELF; Rocking The Boat.” The Wall Street Journal (Thursday, May 9, 2018): A15.
(Note: ellipsis internal to a paragraph, in original; ellipses between paragraphs, added.)
(Note: the online version of the review has the date May 10, 2018, and has the title “BOOKSHELF; ‘In Defense of Troublemakers’ Review: Rocking the Boat.”)

The book under review, is:
Nemeth, Charlan. In Defense of Troublemakers: The Power of Dissent in Life and Business. New York: Basic Books, 2018.

Spreadsheets Created More and Better Jobs Than They Destroyed

BookkeepingVersusAnalystJobsGraph2018-05-19.jpgSource of graph: online version of the WSJ article quoted and cited below.

(p. A2) Whether truck drivers or marketing executives, all workers consider intelligence intrinsic to how they do their jobs. No wonder the rise of “artificial intelligence” is uniquely terrifying. From Stephen Hawking to Elon Musk, we are told almost daily our jobs will soon be done more cheaply by AI.
. . .
Until the 1980s, manipulating large quantities of data–for example, calculating how higher interest rates changed a company’s future profits–was time-consuming and error-prone. Then along came personal computers and spreadsheet programs VisiCalc in 1979, Lotus 1-2-3 in 1983 and Microsoft Excel a few years later. Suddenly, you could change one number–say, this year’s rent–and instantly recalculate costs, revenues and profits years into the future. This simplified routine bookkeeping while making many tasks possible, such as modeling alternate scenarios.
. . .
The new technology pummeled demand for bookkeepers: their ranks have shrunk 44% from two million in 1985, according to the Bureau of Labor Statistics. Yet people who could run numbers on the new software became hot commodities. Since 1985, the ranks of accountants and auditors have grown 41%, to 1.8 million, while financial managers and management analysts, which the BLS didn’t even track before 1983, have nearly quadrupled to 2.1 million.

For the full commentary, see:
Greg Ip. “CAPITAL ACCOUNT; We Survived Spreadsheets; We’ll Survive AI.” The Wall Street Journal (Thursday, August 3, 2017): A2.
(Note: ellipses added.)
(Note: the online version of the commentary was updated Aug. 2, 2017, and has the title “CAPITAL ACCOUNT; We Survived Spreadsheets, and We’ll Survive AI.”)

Vending Machines for Cars in China

(p. B2) GUANGZHOU, China– Eric Zhou is interested in buying a Ford Kuga sport-utility vehicle. So last week, he picked up the car for a three-day test drive from a vending machine.
Mr. Zhou never visited a dealership or spoke to a salesperson. He booked the test drive online, then showed up at a service center where employees can identify would-be buyers using facial-recognition technology. His SUV was then delivered from the eight-story “vending machine”–essentially an automated parking garage.
“This is so much more efficient and convenient than traditional dealerships,” said Mr. Zhou, 38 years old.
It’s the first of several such car-vending centers that Chinese e-commerce giant Alibaba Group Holding Ltd. plans to open across China this year–part of the company’s latest effort to translate its success in online retailing to the physical shopping world.

For the full story, see:
Liza Lin. “Car-Vending Machine Is Rolled Out.” The Wall Street Journal (Friday, April 6, 2018): B2.
(Note: the online version of the story has the date April 5, 2018, and has the title “To Buy a Car in China, Hit the Vending Machine.”)

Mark Twain’s “Desperately Striving Entrepreneurship”

(p. A13) For a novelist with such a tart view of human character, Twain’s gullibility is hard to fathom. No matter his dismal track record, he always appraised the next opportunity as a sure thing. The two fields he knew about, books and newspapers, caused him more grief than any other. He had success with Charles L. Webster & Co., the publisher he founded, which issued the memoirs of Ulysses S. Grant. But after that runaway hit, he published a string of lemons.
Even worse was his decade-long investment in a typesetting machine, the Paige Compositor, which, Twain noted, would be faster than a human typesetter and “does not get drunk” and “does not join the Printer’s Union.” But its inventor proved to be a hopeless perfectionist, his machine with its thousands of parts a tribute to complexity gone mad. Ultimately, Twain invested $175,000–an immense sum. With the mogul Rogers guiding him, the author transferred his assets to his wife and put his publishing company into bankruptcy. Only by embarking on a world-wide speaking tour was he able to pay his debts.
Mr. Crawford doesn’t seem curious about whether Twain’s financial capers informed his writing. He has nothing notable to say, for instance, on “The Prince and the Pauper,” a wry commentary on the sort of class envy to which Twain himself was susceptible. Nor does Mr. Crawford attempt to reconcile the conventional view of Twain as a folksy raconteur with the evidence of his desperately striving entrepreneurship.

For the full review, see:
Roger Lowenstein. “BOOKSHELF; A Pudding Head and His Money; Given the novelist’s tart view of human character, the financial misadventures of Mark Twain are hard to fathom.” The Wall Street Journal (Friday, October 27, 2017): A13.
(Note: the online version of the review has the date Oct. 26, 2017, and has the title “BOOKSHELF; Review: A Pudding Head and His Money; Given the novelist’s tart view of human character, the financial misadventures of Mark Twain are hard to fathom.”)

The book under review, is:
Crawford, Alan Pell. How Not to Get Rich: The Financial Misadventures of Mark Twain. New York: Houghton Mifflin Harcourt, 2017.

Clues to How Macron Achieves Major Free Market Reforms in France

(p. A9) PARIS — The plush red velvet seats of France’s National Assembly are filled with lawmakers who owe just about everything to President Emmanuel Macron.
Three-quarters of the 577 members are brand new, swept into power in the wake of his election last year. More than 60 percent are in his camp. Nearly one-third have never held public office, and 38 were under the age of 31 when they entered office.
. . .
On Thursday [March 22, 2018], tens of thousands of railway workers, teachers and air traffic controllers went on strike across France to protest salary freezes for civil servants and Mr. Macron’s pledge to cut 120,000 public-sector jobs and introduce merit-based pay and use more private contractors.
. . .
The assembly has become a showcase of Mr. Macron’s forceful powers of persuasion and the ways he wants to reshape and update all of France.
“There’s been a complete cultural shock,” said Jean-Paul Delevoye, a senior official in Mr. Macron’s government who helped pick his candidates for Parliament.
“We’ve completely overturned the sociology of the assembly,” he added.
Diet Coke replaced wine as the most popular item at the assembly’s bar. Wine sales had plummeted, stunning the barmen, though they are creeping back up under the influence of long days. Mr. Macron’s acolytes sit through them, unlike their predecessors.
Before the rule for a deputy was, arrive Tuesday morning and go home Wednesday evening. Now, many say, Mr. Macron’s deputies come for the whole week.
So assiduous are they that “now, it’s hard to find a spot at the restaurant, that’s what strikes me,” said Brigitte Bourguignon, another ex-Socialist who joined Mr. Macron.
Among the youthful deputies, common positions are worked out in advance on applications like Telegram, befuddling the old-timers. There is little patience for them in any case.
. . .
Parliament was barely to be seen last year when Mr. Macron forced through changes to France’s rigid labor code to allow companies more flexibility in negotiating directly with workers, and to limit payouts after layoffs.
Instead, the president proceeded by special decree, using a rarely used procedure that allowed the National Assembly merely to vote thumbs up or down on the labor reforms — it voted up — but without the power to change or even discuss them.
Then, Mr. Macron rammed through the lifting of a tax on wealth, insisting that it was necessary to free capital for investment. Many economists agreed. But apart from a few opposition whimpers there was hardly any debate.
In coming weeks he proposes to take on the railway workers — the bête noir of many a French government — again by special decree. Mr. Macron wants to end the hiring-for-life, early retirement and enhanced medical insurance that have contributed to a whopping deficit. But he doesn’t necessarily want Parliament debating it.
. . .
For his dedicated supporters in Parliament, subordination is not an issue. Asked whether he had been in disagreement with the government, Mr. Potterie replied: “Ah, no. No. At the margins maybe. But for the moment, no.”
In the National Assembly, “it’s true that we don’t challenge the government,” he added. “It’s because we were elected to carry out their program.”
That sense of purpose runs deep.
“It’s not true that we are simply puppets,” insisted Ms. Bourguignon, the former Socialist. “We’ve got a government that reforms, and we’ve got to follow the government.”

For the full story, see:
ADAM NOSSITER. “Macron Fills the Role Of French Strongman.” The New York Times (Friday, March 23, 2018): A9.
(Note: ellipses, and bracketed date, added.)
(Note: the online version of the story has the date MARCH 22, 2018, and has the title “Emmanuel Macron Becomes France’s Answer to Strongman Populism.” The online version says that the article appeared on p. A13 of the New York edition. It appeared on p. A9 of my National edition.)

Grünberg Found Useful Effect That Went Against Then-Dominant Theory

(p. A25) Peter Grünberg, a Nobel-Prize-winning physicist who discovered how to store vast amounts of data by manipulating the magnetic and electrical fields of thin layers of atoms, making possible devices like the iPad and the smartphone, has died at 78.
. . .
Since the British physicist Lord Kelvin first wrote about the subject in 1857, it had long been known that magnetic fields could affect the electrical resistance of magnetic materials like iron. Current flowed more easily along the field lines than across them.
While this effect on electrical resistance was useful for sensing magnetic fields and, in electronic heads, reading magnetic disks, it amounted to only a small change in the resistance, and physicists did not think there were many prospects for improvement.
So it was a surprise in 1988 when groups led by Dr. Fert at the Laboratoire de Physique des Solides in Paris and by Dr. Grünberg found that super-slim sandwiches of iron and chromium that they had assembled showed large sensitivity to magnetic fields — or “giant magnetoresistance,” as Dr. Fert called it. The name stuck.
The reason for the effect has to do with what physicists call the spin of electrons — their somewhat mysterious ability to have an orientation in space. When the magnetic layers of the sandwich have both their fields pointing in the same direction, electrons whose spin points along that direction can migrate freely through the sandwich. Electrons that point in another direction, however, are scattered.
If, however, one of the magnetic layers is perturbed by, say, reading a small signal, it can flip its direction so that its field runs opposite to the other one; this dramatically increases the electrical resistance of the sandwich.
As Philip Schewe, of the American Institute of Physics, explained, “You’ve leveraged a weak bit of magnetism into a robust bit of electricity.”
Experts said the discovery was one of the first triumphs of the new field of nanotechnology, the ability to build and manipulate assemblies of atoms only a nanometer (a billionth of a meter) in size.

For the full obituary, see:
DENNIS OVERBYE. “Peter Grünberg, 78, Dies; Heart of Modern Gadgets Is Based on His Research.” The New York Times (Friday, April 13, 2018): A25.
(Note: ellipsis added.)
(Note: the online version of the obituary has the date APRIL 12, 2018, and has the title “Peter Grünberg, 78, Winner of an ‘iPod Nobel,’ Is Dead.”)

Big Pharma Is Mellow about FDA Obstacles to Innovation

It sometimes appears that big pharma is comfortable with the hugely expensive FDA drug approval process. Perhaps big pharma firms have learned how to navigate the process and have the resources to do so. And perhaps the process discourages disruptive innovations from small medical startups that have not learned how to navigate the process, and do not have the resources to do so. If so, then the puzzling indifference of big pharma indicated in the passages quoted below, becomes easier to understand.
(There’s a wonderful recent TV ad from big pharma supporting innovation by quoting the Dylan Thomas poem saying we should “rage, rage against the dying of the light.” If only they really meant it.)

(p. A13) In recent years, the arrival of breakthrough drugs for everything from cancer to rare diseases has led to a surge in the number of patients wanting early access to treatments. The pleas — sometimes driven by viral social media campaigns — have proved vexing for companies that have invested millions to get a drug to market and are wary of doing anything to jeopardize their chances.

Today, companies’ policies on granting early access to drugs are a confusing patchwork that tends to favor affluent and well-connected patients at leading medical centers, who have the resources and know-how to navigate the system.
“You have to be pretty sophisticated,” said Dr. Arthur L. Caplan, a bioethicist at New York University who has been working with companies, including Johnson & Johnson, to develop better early-access programs. But the bill passed this week, he said, “does somewhere between nothing and absolutely nothing to help you.”
The bill’s passage represented a victory for proponents of “right to try,” a campaign championed by Vice President Mike Pence and initiated by the Goldwater Institute, a libertarian think tank that favors limiting the scope of the F.D.A. At least 38 states have passed local versions of right-to-try laws, which allow patients to sidestep F.D.A. approval once they have received permission from a company.
The right-to-try measures are opposed by a broad coalition of groups, which contend the bill will not help patients and will undermine the authority of the primary regulatory agency, the F.D.A. Four former F.D.A. commissioners, including two each from Democratic and Republican administrations, oppose the bills, as do dozens of patient groups, including the American Cancer Society Cancer Action Network and the American Lung Association.
The pharmaceutical industry, while not taking a position on the issue, has been circumspect. A spokesman for its main lobbying group, the Pharmaceutical Research and Manufacturers of America, said on Friday, “We believe any legislation must truly benefit and protect patients and not disrupt the future of clinical trials, U.S. Food and Drug Administration oversight and the research and approval of new medicines.”
. . .
The F.D.A. already approves 99 percent of such applications, and the agency has streamlined the approval process. Drug companies also have many other reasons to bar access — often, companies do not have enough extra product to give to patients, or they worry that the logistical work of granting access could slow efforts to get the drug approved, when it would become available to any patient who needed it.
There is also the possibility that the drug does not work — many experimental products fail in late-stage trials.
. . .
“In our view, the F.D.A. plays a really important role,” Dr. Joanne Waldstreicher, the chief medical officer of Johnson & Johnson, said in an interview Thursday. Johnson & Johnson initiated a program in 2015 that delegates decisions about early access to a program set up by Dr. Caplan. The F.D.A., Dr. Waldstreicher said, has “information that we don’t have necessarily; they see safety and efficacy information on products that may be similar.”

For the full story, see:
KATIE THOMAS. “For Terminally Ill People, a Convoluted Procedure Just to Give Drugs a Try.” The New York Times (Saturday, March 24, 2018): A13.
(Note: ellipses added.)
(Note: the online version of the story has the date March 23, 2018, and has the title “Why Can’t Dying Patients Get the Drugs They Want?”)